Ye. S. Kozachuk
Ye. S. Kozachuk has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- L. M. Semenyuk
Український науково-практичний центр ендокринної хірургії, трансплантації ендокринних органів і тканин МОЗ України, Київ
9 shared publications - Oleksandr A. Tovkai
Український науково-практичний центр ендокринної хірургії, трансплантації ендокринних органів і тканин МОЗ України, Київ
8 shared publications - Volodymyr O. Palamarchuk
Український науково-практичний центр ендокринної хірургії, трансплантацїї ендокринних органів і тканин Міністерства охорони здоров’я України, Київ
8 shared publications Т. Ю. Юзвенко
Український науково-практичний центр ендокринної хірургії, трансплантації ендокринних органів і тканин МОЗ України, Київ
8 shared publications- Tetyana Yuzvenko
Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine, Kyiv, Ukraine
6 shared publications - O. I. Kryzhanovska
Institute of Postgraduate Education, Bogomolets National Medical University, Kyiv, Ukraine
5 shared publications
Latest Publications
- Open Access
- 17 April 2026
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 93 (2) , 89-91
A Unique Combination of Urgent Gynecological and Surgical Pathologies
A Unique Combination of Urgent Gynecological and Surgical Pathologies
- 17 April 2026
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 93 (2) , 89-91
Open AccessA Unique Combination of Urgent Gynecological and Surgical Pathologies
A Unique Combination of Urgent Gynecological and Surgical Pathologies
- Open Access
- 30 September 2025
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 3,p. 63-72
Альтернативні підходи в лікуванні ендометріозу. Огляд літератури
Ендометріоз — це хронічне захворювання з багатьма виявами, основними з яких є біль і безпліддя. Захворювання зумовлене появою ендометрійподібних груп клітин, що складаються з ендометріоїдних залозистих клітин та/або стромальних клітин поза порожниною матки. Доведено, що тканина ендометрію, яка мігрує, виробляє естроген, взаємодіє з ендокринною, опорно‑руховою, судинною, репродуктивною та нервовою системами організму, що призводить до симптомів ендометріозу різної виразності, та трапляється в жінок будь‑якого віку. Складність лікування цього захворювання зумовлена хронічним перебігом і частим рецидуванням після хірургічного видалення. Тому існує нагальна потреба в розробці альтернативних або додаткових методів лікування ендометріозу з тривалими протирецидивними властивостями та мінімальною кількістю побічних ефектів за тривалого використання. Основними альтернативними підходами в лікуванні ендометріозу є заходи, що зменшують вплив оксидантного стресу, дають змогу усунути запальний процес, відновити гормонально‑імунний баланс в організмі жінки, впливають на проангіогенні й епігенетичні складові захворювання. Для цього використовують засоби відновлення кишкової мікробіоти, дієту з низьким вмістом олігосахаридів, дисахаридів, моносахаридів і поліолів, препарати рослинної дії, амінокислоти, комбіновані добавки мікроелементів, фізіотерапевтичні методики впливу на больовий синдром. Висновки. Харчові добавки мають позитивний вплив при лікуванні ендометріозу. Деякі з них можна застосовувати як додаткове лікування симптомів жіночої сексуальної дисфункції. Лікування має бути персоніфікованим з урахуванням репродуктивних планів жінок, віку діагностування ендометріозу, форми та стадії захворювання, супутньої патології (ендокринно‑імунні розлади). Використання рослинних препаратів потребує дослідження, зокрема їхнього впливу на рівні центральних гормонів гіпофіза.
- 30 September 2025
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 3,p. 63-72
Open AccessАльтернативні підходи в лікуванні ендометріозу. Огляд літератури
Ендометріоз — це хронічне захворювання з багатьма виявами, основними з яких є біль і безпліддя. Захворювання зумовлене появою ендометрійподібних груп клітин, що складаються з ендометріоїдних залозистих клітин та/або стромальних клітин поза порожниною матки. Доведено, що тканина ендометрію, яка мігрує, виробляє естроген, взаємодіє з ендокринною, опорно‑руховою, судинною, репродуктивною та нервовою системами організму, що призводить до симптомів ендометріозу різної виразності, та трапляється в жінок будь‑якого віку. Складність лікування цього захворювання зумовлена хронічним перебігом і частим рецидуванням після хірургічного видалення. Тому існує нагальна потреба в розробці альтернативних або додаткових методів лікування ендометріозу з тривалими протирецидивними властивостями та мінімальною кількістю побічних ефектів за тривалого використання. Основними альтернативними підходами в лікуванні ендометріозу є заходи, що зменшують вплив оксидантного стресу, дають змогу усунути запальний процес, відновити гормонально‑імунний баланс в організмі жінки, впливають на проангіогенні й епігенетичні складові захворювання. Для цього використовують засоби відновлення кишкової мікробіоти, дієту з низьким вмістом олігосахаридів, дисахаридів, моносахаридів і поліолів, препарати рослинної дії, амінокислоти, комбіновані добавки мікроелементів, фізіотерапевтичні методики впливу на больовий синдром. Висновки. Харчові добавки мають позитивний вплив при лікуванні ендометріозу. Деякі з них можна застосовувати як додаткове лікування симптомів жіночої сексуальної дисфункції. Лікування має бути персоніфікованим з урахуванням репродуктивних планів жінок, віку діагностування ендометріозу, форми та стадії захворювання, супутньої патології (ендокринно‑імунні розлади). Використання рослинних препаратів потребує дослідження, зокрема їхнього впливу на рівні центральних гормонів гіпофіза.
- Open Access
- 30 June 2025
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 2,p. 5-12
Parathyroid cancer: parathyroid hormone as a predictor of malignancy
The clinical manifestation of parathyroid cancer (PC) is quite diverse and can mask different diseases. Classical symptoms of primary hyperparathyroidism (PHPT) with significant increases in calcium and parathyroid hormone (PTH) levels in the blood are still present. Currently, no laboratory test can diagnose PC in the pre-operative period. A clinical presentation, with the combination of a significantly increased level of PTH and calcium, primarily allows suspicion of PC in a patient with PHPT. Objective — to evaluate the diagnostic value of parathyroid hormone as a predictor of malignant parathyroid lesions. Materials and methods. Pre- and post-surgical examination data from 216 patients with PHPT were analyzed. Increased levels of PTH and ionized calcium (Ca2+) were diagnosed in all patients preoperatively. All patients underwent parathyroidectomy. Following to post-surgical pathohistology, patients (n=216) were divided into 2 groups: I group (n=28) — the main group–patients with PHPT and postoperatively confirmed diagnosis of PC; II group (n=188) — the comparison group — patients with PHPT and parathyroid adenoma. The study’s primary endpoint was to identify and analyze the possibility of using preoperative PTH levels as a predictor of malignant processes. The secondary endpoints were to find the correlation between tumor size, tumor weight, and laboratory findings, including the level of PTH and calcium in benign and malignant parathyroid lesions, and to analyze rare forms of PC. Results. Preoperative levels of PTH and Ca2+ differed significantly between the study groups (p<0.001). ROC analysis showed that both indicators can be used as predictors of the presence of malignancy. However, preoperative PTH level is significantly more effective. The sensitivity for PTH test in PC diagnosis was 0.964, and the specificity was 0.888. Attention should be paid to the lower PTH cut-off threshold of 280.8 pg/mL. For Ca2+ test, the sensitivity in PC diagnosis was 0.857, and the specificity was 0.878. Statistically confirmed correlations between tumor size and weight and laboratory parameters were not found in our study. Conclusions. There were no statistically confirmed correlations between parathyroid hormone, ionized calcium, and tumor size or weight in our study. Most patients with benign parathyroid adenomas (70%) were in the range of PTH values ≤280 pg/mL, which can be considered «safe». The level of PTH ≥280 pg/mL suggests the potential presence of clear-cell PC. The PTH cut-off threshold ≥502 pg/mL potentially corresponds to the presence of parathyroid carcinoma with a classical histological structure, after which the incidence is 78%. Surgical approach in cases of PTH ≥502 pg/mL should be planned on the principles of cancer surgery. Determining the predictors of PC requires further study.
- 30 June 2025
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 2,p. 5-12
Open AccessParathyroid cancer: parathyroid hormone as a predictor of malignancy
The clinical manifestation of parathyroid cancer (PC) is quite diverse and can mask different diseases. Classical symptoms of primary hyperparathyroidism (PHPT) with significant increases in calcium and parathyroid hormone (PTH) levels in the blood are still present. Currently, no laboratory test can diagnose PC in the pre-operative period. A clinical presentation, with the combination of a significantly increased level of PTH and calcium, primarily allows suspicion of PC in a patient with PHPT. Objective — to evaluate the diagnostic value of parathyroid hormone as a predictor of malignant parathyroid lesions. Materials and methods. Pre- and post-surgical examination data from 216 patients with PHPT were analyzed. Increased levels of PTH and ionized calcium (Ca2+) were diagnosed in all patients preoperatively. All patients underwent parathyroidectomy. Following to post-surgical pathohistology, patients (n=216) were divided into 2 groups: I group (n=28) — the main group–patients with PHPT and postoperatively confirmed diagnosis of PC; II group (n=188) — the comparison group — patients with PHPT and parathyroid adenoma. The study’s primary endpoint was to identify and analyze the possibility of using preoperative PTH levels as a predictor of malignant processes. The secondary endpoints were to find the correlation between tumor size, tumor weight, and laboratory findings, including the level of PTH and calcium in benign and malignant parathyroid lesions, and to analyze rare forms of PC. Results. Preoperative levels of PTH and Ca2+ differed significantly between the study groups (p<0.001). ROC analysis showed that both indicators can be used as predictors of the presence of malignancy. However, preoperative PTH level is significantly more effective. The sensitivity for PTH test in PC diagnosis was 0.964, and the specificity was 0.888. Attention should be paid to the lower PTH cut-off threshold of 280.8 pg/mL. For Ca2+ test, the sensitivity in PC diagnosis was 0.857, and the specificity was 0.878. Statistically confirmed correlations between tumor size and weight and laboratory parameters were not found in our study. Conclusions. There were no statistically confirmed correlations between parathyroid hormone, ionized calcium, and tumor size or weight in our study. Most patients with benign parathyroid adenomas (70%) were in the range of PTH values ≤280 pg/mL, which can be considered «safe». The level of PTH ≥280 pg/mL suggests the potential presence of clear-cell PC. The PTH cut-off threshold ≥502 pg/mL potentially corresponds to the presence of parathyroid carcinoma with a classical histological structure, after which the incidence is 78%. Surgical approach in cases of PTH ≥502 pg/mL should be planned on the principles of cancer surgery. Determining the predictors of PC requires further study.
- Open Access
- 30 June 2025
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 2,p. 13-19
Autoimmune thyroid diseases and their impact on sexual and reproductive function in young women
Objective — to determine the relationship between the characteristics of the hormonal background and signs of FSD in women with ATD in the prediction of the success of future gestation and the formation of POF. Materials and methods. The study design is a prospective study that included 30 women of reproductive age (main group) with ATD and 30 healthy women of reproductive age — the control group. The levels of steroid and peptide hormones, domains of FSD and the ovulatory phase of the menstrual cycle were studied during 9 months of therapy. The presence of female sexual dysfunction was determined using a questionnaire with scoring on an online calculator. The treatment included the use of a complex of herbal remedies recommended for hypoandrogenic ovarian dysfunction. Statistical analysis was performed using the specialized statistical software package SPSS 25.0 (StatSoft Inc., USA). Results. All women in the main group had a combination of signs of FSD with anovulation against the background of clinically significant TPOAb indicators. Correlations were established: statistically significant relationship between desire and 17-OP indicators; arousal and progesterone; orgasm and TPOAb, TSH, progesterone; pain and homocysteine, TSH; FSFI and TSH, between questionnaire scores and hormonal indicators: orgasm and vitamin D; AMH and pleasure, pain, FSFI (p<0.05). After 9 months of therapy, 60.0% (n=18) of the patients in the main group had persistent DHEA-S deficiency. Monitoring of ovulation by ultrasound folliculometry in the main group indicated a negative prognosis for natural pregnancy in 16 (53.3%) of the examined. Conclusions. Familiarity of doctors of related specialties with the problem of autoimmune thyroid pathology and its consequences for the sexual and reproductive health of women can improve their awareness of the individualized prognosis of pregnancy. Pregnancy planning in women with ATD with an emphasis on their age and the value of thyroid antibody titers. Determination of reproductive steroidogenesis along with examination of the thyroid panel. With low DHEA-S indicators — indications for examination of adrenal function.
- 30 June 2025
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 2,p. 13-19
Open AccessAutoimmune thyroid diseases and their impact on sexual and reproductive function in young women
Objective — to determine the relationship between the characteristics of the hormonal background and signs of FSD in women with ATD in the prediction of the success of future gestation and the formation of POF. Materials and methods. The study design is a prospective study that included 30 women of reproductive age (main group) with ATD and 30 healthy women of reproductive age — the control group. The levels of steroid and peptide hormones, domains of FSD and the ovulatory phase of the menstrual cycle were studied during 9 months of therapy. The presence of female sexual dysfunction was determined using a questionnaire with scoring on an online calculator. The treatment included the use of a complex of herbal remedies recommended for hypoandrogenic ovarian dysfunction. Statistical analysis was performed using the specialized statistical software package SPSS 25.0 (StatSoft Inc., USA). Results. All women in the main group had a combination of signs of FSD with anovulation against the background of clinically significant TPOAb indicators. Correlations were established: statistically significant relationship between desire and 17-OP indicators; arousal and progesterone; orgasm and TPOAb, TSH, progesterone; pain and homocysteine, TSH; FSFI and TSH, between questionnaire scores and hormonal indicators: orgasm and vitamin D; AMH and pleasure, pain, FSFI (p<0.05). After 9 months of therapy, 60.0% (n=18) of the patients in the main group had persistent DHEA-S deficiency. Monitoring of ovulation by ultrasound folliculometry in the main group indicated a negative prognosis for natural pregnancy in 16 (53.3%) of the examined. Conclusions. Familiarity of doctors of related specialties with the problem of autoimmune thyroid pathology and its consequences for the sexual and reproductive health of women can improve their awareness of the individualized prognosis of pregnancy. Pregnancy planning in women with ATD with an emphasis on their age and the value of thyroid antibody titers. Determination of reproductive steroidogenesis along with examination of the thyroid panel. With low DHEA-S indicators — indications for examination of adrenal function.
- Open Access
- 22 May 2025
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 21 (3) , 306-313
Determining the relationship between hormonal background characteristics and signs of female sexual dysfunction in women with and without endometriosis in the prediction of gestational success
Background. Overcoming infertility in young women is recognized as one of the most important tasks of modern medicine. Among the factors that reduce female fertility, endometriosis remains relevant. The widespread prevalence of diseases with common pathogenetic factors has led to the emergence of diseases of “old age” in women of reproductive age. These include, in particular, female sexual dysfunction (FSD). The relationship between FSD and hormonal indicators as prognostic factors of female reproductive health has been little studied to date. The purpose was to determine the relationship between the characteristics of the hormonal background and signs of FSD in women with and without endometriosis in the prediction of the success of future gestation. Materials and methods. The study design is a prospective cohort study, which included 130 women of reproductive age. They were divided into 3 groups: group IA (n = 70) — a combination of female sexual dysfunction and extragenital endometriosis, the comparison group IB (n = 30) — female sexual dysfunction without extragenital endometriosis, the control group II (n = 30) — healthy reproductively active women. The end points of the study were levels of pituitary and ovarian hormones, proandrogenic steroids, ovulatory menstrual cycles. These indicators were studied before treatment and at the control periods of therapy — 3, 6, 9 months. The presence of FSD was determined using a questionnaire with scoring on an online calculator, when the female sexual function index was less than 26.55 points. The therapy was aimed at restoring the correct functioning of ovarian steroidogenesis using herbal therapy. Statistical analysis was performed using a specialized statistical software package SPSS 25.0 (StatSoft Inc., USA). Results. A significant normalization of pituitary peptide hormones in the comparison groups occurred in the period from the sixth to the ninth month of therapy. As for the estradiol level, its significant increase was noted in both comparison groups throughout the entire observation period. At the ninth month, the values of progesterone in patients with FSD and endometriosis were significantly higher in than those without it (p = 0.002). Despite the treatment, the estradiol and progesterone levels in the IA group remained significantly lower than in the control group throughout the entire observation period (p < 0.001). In patients without endometriosis (IB group), after 9 months of treatment, only estrogen values were successfully corrected, which were comparable to the control group. Analysis using Dunn’s test with Bonferroni correction showed no statistically significant difference between the IA and IV groups throughout the entire course of treatment (p > 0.05). Correlation analysis revealed that in patients with FSD and endometriosis after 6 months of treatment, changes in the studied hormones statistically significantly correlated with improvements in scores in all domains of the questionnaire. At the control period of 6 months, 20 (66.3 %) women were not ready for safe conception. In the 9-month control period, 16 (53.3 %) patients in this group were not ready for safe motherhood. Conclusions. Women with external-internal endometriosis and FSD and women with FSD alone have different pathogenetic background in the formation of gestational pathology. Therapy of patients with any form of FSD should be personalized. Assessment of FSD domains allows for rapid diagnosis of future gestational risks in women of reproductive age.
- 22 May 2025
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 21 (3) , 306-313
Open AccessDetermining the relationship between hormonal background characteristics and signs of female sexual dysfunction in women with and without endometriosis in the prediction of gestational success
Background. Overcoming infertility in young women is recognized as one of the most important tasks of modern medicine. Among the factors that reduce female fertility, endometriosis remains relevant. The widespread prevalence of diseases with common pathogenetic factors has led to the emergence of diseases of “old age” in women of reproductive age. These include, in particular, female sexual dysfunction (FSD). The relationship between FSD and hormonal indicators as prognostic factors of female reproductive health has been little studied to date. The purpose was to determine the relationship between the characteristics of the hormonal background and signs of FSD in women with and without endometriosis in the prediction of the success of future gestation. Materials and methods. The study design is a prospective cohort study, which included 130 women of reproductive age. They were divided into 3 groups: group IA (n = 70) — a combination of female sexual dysfunction and extragenital endometriosis, the comparison group IB (n = 30) — female sexual dysfunction without extragenital endometriosis, the control group II (n = 30) — healthy reproductively active women. The end points of the study were levels of pituitary and ovarian hormones, proandrogenic steroids, ovulatory menstrual cycles. These indicators were studied before treatment and at the control periods of therapy — 3, 6, 9 months. The presence of FSD was determined using a questionnaire with scoring on an online calculator, when the female sexual function index was less than 26.55 points. The therapy was aimed at restoring the correct functioning of ovarian steroidogenesis using herbal therapy. Statistical analysis was performed using a specialized statistical software package SPSS 25.0 (StatSoft Inc., USA). Results. A significant normalization of pituitary peptide hormones in the comparison groups occurred in the period from the sixth to the ninth month of therapy. As for the estradiol level, its significant increase was noted in both comparison groups throughout the entire observation period. At the ninth month, the values of progesterone in patients with FSD and endometriosis were significantly higher in than those without it (p = 0.002). Despite the treatment, the estradiol and progesterone levels in the IA group remained significantly lower than in the control group throughout the entire observation period (p < 0.001). In patients without endometriosis (IB group), after 9 months of treatment, only estrogen values were successfully corrected, which were comparable to the control group. Analysis using Dunn’s test with Bonferroni correction showed no statistically significant difference between the IA and IV groups throughout the entire course of treatment (p > 0.05). Correlation analysis revealed that in patients with FSD and endometriosis after 6 months of treatment, changes in the studied hormones statistically significantly correlated with improvements in scores in all domains of the questionnaire. At the control period of 6 months, 20 (66.3 %) women were not ready for safe conception. In the 9-month control period, 16 (53.3 %) patients in this group were not ready for safe motherhood. Conclusions. Women with external-internal endometriosis and FSD and women with FSD alone have different pathogenetic background in the formation of gestational pathology. Therapy of patients with any form of FSD should be personalized. Assessment of FSD domains allows for rapid diagnosis of future gestational risks in women of reproductive age.
- Open Access
- 31 March 2025
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 1,p. 5-12
Perioperative diagnosis of various variants of papillary thyroid cancer in children and adolescents: 15-year experience of the Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissue of MoH of Ukraine
The issues of risk stratification of papillary thyroid cancer (PTC) at the preoperative stage in children and adolescents remain insufficiently studied, in Ukraine in particular. The importance of further enhancing our knowledge on this issue remains significant. Objective to analyze the results of perioperative examinations of patients with different variants of PTC. Materials and methods. The study design was a single‑center retrospective cohort study. The medical records of 106 patients with PTC who underwent examination and treatment at the Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine from 2010 to 2024 were analyzed. Depending on the variant of the PTC, patients were divided into 3 groups: Group I — multifocal variant (MF); Group II — mono‑focal variant (MonoF), and Group III — diffuse sclerosing variant (DSV). The endpoints of the study were: 1) levels of thyroid‑stimulating hormone (TSH), antithyroperoxidase antibodies (TPO‑Ab), antithyroglobulin antibodies (TG‑Ab); 2) ultrasound examination (US) of the thyroid gland and neck; 3) cytological findings of the biopsy material according to the Bethesda classification; 4) results of pathological histological examination (PHE) of postoperative material; 5) stage of the thyroid cancer process according to TNM classification. Results. No statistically significant differences were found between the study groups in terms of TSH, TPO‑Ab, and TG‑Ab levels. Thyroid parenchyma microcalcification, hypoechogenicity, indistinctness, irregularity of borders, and the presence of microcalcifications of the dominant node and grade 5 by system Thyroid Imaging Reporting and Data System (TI‑RADS) were statistically significant in patients with DSV (p<0.05). The detection rate of altered neck lymph nodes via sonography was significantly higher in the DSV group than in the MonoF and MF groups, p<0.05. All patients in this group had Bethesda grade 6 cytologic findings. In the DSV group, by pathological histology, foci with a diameter of more than 40 mm, the absence of a tumor capsule, vascular invasion, intrathyroid and extraorganic tumor invasion were statistically significantly more common, p0.05. According to the classification of TNM in the DSV group, compared with other groups, the pT3 (46.7%), (p<0.01), N1b (73.3%), (p<0.01), and less often — pN0 (3.3%), (p<0.05) were detected more often. Conclusions. Sonographic signs such as blurred borders, microcalcifications of the dominant node, enlarged cervical lymph nodes, and parenchyma microcalcifications indicate the likelihood of DSV PTC. DSV PTC is characterized by pronounced pathologic signs of tumor aggressiveness and a higher level of metastasis in cervical lymph nodes compared with non‑DSV variants of PTC. The thyroid lesions and cervical lymph nodes in children and adolescents especially need to be improved at the preoperative stage, as they can play a significant role in predicting more aggressive forms of PTC.
- 31 March 2025
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 1,p. 5-12
Open AccessPerioperative diagnosis of various variants of papillary thyroid cancer in children and adolescents: 15-year experience of the Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissue of MoH of Ukraine
The issues of risk stratification of papillary thyroid cancer (PTC) at the preoperative stage in children and adolescents remain insufficiently studied, in Ukraine in particular. The importance of further enhancing our knowledge on this issue remains significant. Objective to analyze the results of perioperative examinations of patients with different variants of PTC. Materials and methods. The study design was a single‑center retrospective cohort study. The medical records of 106 patients with PTC who underwent examination and treatment at the Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine from 2010 to 2024 were analyzed. Depending on the variant of the PTC, patients were divided into 3 groups: Group I — multifocal variant (MF); Group II — mono‑focal variant (MonoF), and Group III — diffuse sclerosing variant (DSV). The endpoints of the study were: 1) levels of thyroid‑stimulating hormone (TSH), antithyroperoxidase antibodies (TPO‑Ab), antithyroglobulin antibodies (TG‑Ab); 2) ultrasound examination (US) of the thyroid gland and neck; 3) cytological findings of the biopsy material according to the Bethesda classification; 4) results of pathological histological examination (PHE) of postoperative material; 5) stage of the thyroid cancer process according to TNM classification. Results. No statistically significant differences were found between the study groups in terms of TSH, TPO‑Ab, and TG‑Ab levels. Thyroid parenchyma microcalcification, hypoechogenicity, indistinctness, irregularity of borders, and the presence of microcalcifications of the dominant node and grade 5 by system Thyroid Imaging Reporting and Data System (TI‑RADS) were statistically significant in patients with DSV (p<0.05). The detection rate of altered neck lymph nodes via sonography was significantly higher in the DSV group than in the MonoF and MF groups, p<0.05. All patients in this group had Bethesda grade 6 cytologic findings. In the DSV group, by pathological histology, foci with a diameter of more than 40 mm, the absence of a tumor capsule, vascular invasion, intrathyroid and extraorganic tumor invasion were statistically significantly more common, p0.05. According to the classification of TNM in the DSV group, compared with other groups, the pT3 (46.7%), (p<0.01), N1b (73.3%), (p<0.01), and less often — pN0 (3.3%), (p<0.05) were detected more often. Conclusions. Sonographic signs such as blurred borders, microcalcifications of the dominant node, enlarged cervical lymph nodes, and parenchyma microcalcifications indicate the likelihood of DSV PTC. DSV PTC is characterized by pronounced pathologic signs of tumor aggressiveness and a higher level of metastasis in cervical lymph nodes compared with non‑DSV variants of PTC. The thyroid lesions and cervical lymph nodes in children and adolescents especially need to be improved at the preoperative stage, as they can play a significant role in predicting more aggressive forms of PTC.
- Open Access
- 31 March 2025
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 1,p. 13-21
Management of vitamin D deficiency and hypothyroidism in pre-pregnancy preparation of women with sexual dysfunction associated with endometriosis
In modern conditions, infertile women have a high percentage of so‑called «diseases of civilization»: autoimmune thyroid disorders, dysmetabolic processes, endometriosis, and female sexual dysfunction. Researchers note the role of vitamin D deficiency or insufficiency in the manifestations of these pathological conditions. The lack of an integrated assessment of health and a clear personalized approach when prescribing treatment gives the pathological process a chronic nature and sometimes leads to a persistent loss of fertility. Objective — to determine the relationship between the features of FSD in women with and without endometriosis and changes in hormonal support of reproductive function during the control periods of therapy. Materials and methods. Study design — prospective cohort study, which included 130 women of reproductive age. Patients were stratified into 3 groups according to diagnosed female sexual dysfunction and external genital endometriosis: Group IA (n=70) — main group — women with a combination of female sexual dysfunction and external genital endometriosis; Group IB (n=30) — comparison group — women with female sexual dysfunction without external genital endometriosis; Group II (n=30) — control group — healthy reproductively active women. Management of low vitamin D levels and thyroid hypofunction was carried out as part of complex therapy for hormonal homeostasis disorders. The study endpoints were: 1. Vitamin D levels, Thyroid peroxidase (TPO) antibody (TPO‑Ab) levels, Thyroid stimulating hormone (TSH) levels, FSD. The indicated indicators were studied before treatment and at the control periods of therapy — 3, 6, 9 months. Biochemical studies were conducted in the clinical laboratory of biochemical, hormonal and immunological studies of the Ukrainian Scientific and Practical Center for Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine. Female sexual dysfunction was assessed using a validated questionnaire with scoring conducted via an online calculator. The presence of FSD was determined when the value of the female sexual function index (FSFI) was less than 26.55 points. Statistical analysis was performed using the specialized statistical software package SPSS 25.0 (StatSoft Inc., USA). Results. In women with FSD, regardless of the presence of endometriosis, a statistically significant increase in vitamin D was achieved 3 months after the start of therapy, with positive dynamics maintained until the 9th month, p<0.001. In the comparison groups, changes in the thyroid hormone profile were noted at these times: a statistically significant decrease in the average values of TPO‑Ab after 3 months (p<0.001) and TSH after 6 months from the start of treatment (p<0.001). Regarding TSH values, a statistically significant difference was observed between patients in groups IA and IB at the 6‑month and 9‑month marks, with levels being higher in IA (p=0.006 and p=0.018, respectively). These laboratory parameters were statistically significantly higher in women with FSD compared to the control group throughout the entire observation period, p0.05. However, in women who persisted FSD, vitamin D deficiency was significantly more often detected (p<0.05). Using binary logistic regression, it was found that only the maintenance of functionally elevated TSH levels was a predictive factor for the maintenance of FSD in this cohort of patients. Linear regression analysis showed that in patients with endometriosis, only increased vitamin D levels significantly improved scores in all categories of the FSD questionnaire. Conclusions. Combined correction of vitamin D and TSH levels allows to achieve a positive therapeutic effect in women with both endometriosis and monoform. Reducing TSH levels in women with and without endometriosis significantly affects the frequency of detection of VSD against the background of treatment and improves its manifestations in the categories of «Desire», «Lubrication», «Orgasm» and «Pain» in patients without endometriosis. Therefore, the preservation of functionally elevated TSH levels is a prognostic factor for the preservation of FSD in women. Endometriosis worsens the response of the woman’s body to the prescribed treatment, which requires individualized medical tactics at the pre‑gravid stage.
- 31 March 2025
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 1,p. 13-21
Open AccessManagement of vitamin D deficiency and hypothyroidism in pre-pregnancy preparation of women with sexual dysfunction associated with endometriosis
In modern conditions, infertile women have a high percentage of so‑called «diseases of civilization»: autoimmune thyroid disorders, dysmetabolic processes, endometriosis, and female sexual dysfunction. Researchers note the role of vitamin D deficiency or insufficiency in the manifestations of these pathological conditions. The lack of an integrated assessment of health and a clear personalized approach when prescribing treatment gives the pathological process a chronic nature and sometimes leads to a persistent loss of fertility. Objective — to determine the relationship between the features of FSD in women with and without endometriosis and changes in hormonal support of reproductive function during the control periods of therapy. Materials and methods. Study design — prospective cohort study, which included 130 women of reproductive age. Patients were stratified into 3 groups according to diagnosed female sexual dysfunction and external genital endometriosis: Group IA (n=70) — main group — women with a combination of female sexual dysfunction and external genital endometriosis; Group IB (n=30) — comparison group — women with female sexual dysfunction without external genital endometriosis; Group II (n=30) — control group — healthy reproductively active women. Management of low vitamin D levels and thyroid hypofunction was carried out as part of complex therapy for hormonal homeostasis disorders. The study endpoints were: 1. Vitamin D levels, Thyroid peroxidase (TPO) antibody (TPO‑Ab) levels, Thyroid stimulating hormone (TSH) levels, FSD. The indicated indicators were studied before treatment and at the control periods of therapy — 3, 6, 9 months. Biochemical studies were conducted in the clinical laboratory of biochemical, hormonal and immunological studies of the Ukrainian Scientific and Practical Center for Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine. Female sexual dysfunction was assessed using a validated questionnaire with scoring conducted via an online calculator. The presence of FSD was determined when the value of the female sexual function index (FSFI) was less than 26.55 points. Statistical analysis was performed using the specialized statistical software package SPSS 25.0 (StatSoft Inc., USA). Results. In women with FSD, regardless of the presence of endometriosis, a statistically significant increase in vitamin D was achieved 3 months after the start of therapy, with positive dynamics maintained until the 9th month, p<0.001. In the comparison groups, changes in the thyroid hormone profile were noted at these times: a statistically significant decrease in the average values of TPO‑Ab after 3 months (p<0.001) and TSH after 6 months from the start of treatment (p<0.001). Regarding TSH values, a statistically significant difference was observed between patients in groups IA and IB at the 6‑month and 9‑month marks, with levels being higher in IA (p=0.006 and p=0.018, respectively). These laboratory parameters were statistically significantly higher in women with FSD compared to the control group throughout the entire observation period, p0.05. However, in women who persisted FSD, vitamin D deficiency was significantly more often detected (p<0.05). Using binary logistic regression, it was found that only the maintenance of functionally elevated TSH levels was a predictive factor for the maintenance of FSD in this cohort of patients. Linear regression analysis showed that in patients with endometriosis, only increased vitamin D levels significantly improved scores in all categories of the FSD questionnaire. Conclusions. Combined correction of vitamin D and TSH levels allows to achieve a positive therapeutic effect in women with both endometriosis and monoform. Reducing TSH levels in women with and without endometriosis significantly affects the frequency of detection of VSD against the background of treatment and improves its manifestations in the categories of «Desire», «Lubrication», «Orgasm» and «Pain» in patients without endometriosis. Therefore, the preservation of functionally elevated TSH levels is a prognostic factor for the preservation of FSD in women. Endometriosis worsens the response of the woman’s body to the prescribed treatment, which requires individualized medical tactics at the pre‑gravid stage.
- Open Access
- 31 December 2024
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 4,p. 51-56
Individualized approach in the management of women with female sexual dysfunction, external genital endometriosis and hyperhomocysteinemia
The problem of treatment of endometriosis in women of reproductive age remains an urgent task for obstetricians and gynecologists, as it has a direct impact on women’s ability to conceive. Overcoming the demographic crisis in Ukraine requires doctors to find new methods and techniques in a personalized approach to the treatment of women with endometriosis. The presence of comorbid pathology in endometriosis, in particular hyperhomocysteinemia (HHC) and female sexual dysfunction (FSD), necessitates individualization of the management of such patients. Objective — to determine the effect of surgical treatment of women with external‑intraoral endometriosis and female sexual dysfunction and hyperhomocysteinemia on the characteristics of their hormonal homeostasis and indicators of FSD. Materials and methods. The study included 19 patients with external‑intrinsic endometriosis and female sexual dysfunction and hyperhomocysteinemia with homozygous form of MTRF gene polymorphism. Surgical intervention in the form of laparoscopic cystectomy was performed in 12 patients (group I). 7 patients refused to undergo surgery (group II). Surgical intervention was performed 6 months after the start of treatment. The hormonal status and parameters of the FSD were studied according to the results of a questionnaire at the time of treatment, 6 months after the start of conservative therapy, and 3 months after surgery. Results. At 3 months after surgery, the values of vitamin D, FSH, LH, estradiol, progesterone, free T, DHEA‑S and 17‑OH were statistically significantly higher in women of group I compared with patients who did not undergo surgery — II (p<0.05), and the levels of homocysteine, TSH, prolactin were lower (p<0.05). In patients of group I, a statistically significant increase in questionnaire scores was noted after surgery compared with patients who did not undergo surgery at a significance level of p<0.001. Against the background of the total duration of treatment (6 months of conservative therapy + 3 months of combined treatment — conservative therapy + surgery) in patients of group I with a homozygous mutation, it was possible to achieve normalization of the FSD in all 12 (100.0%) patients. In patients who did not undergo surgery, no normalization of FSD was observed. Conclusions. The treatment of women with FSD and external genital endometriosis should be individualized, taking into account the entire clinical problem, including the impact of the disease and the impact of its treatment on the quality of life. Pregravidar preparation of women with LBP and BPH and hypoandrogenism in homozygous carriage of MTRF polymorphism genes should include surgical removal of ovarian endometrioma to improve LBP and hormonal background for pregnancy.
- 31 December 2024
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 4,p. 51-56
Open AccessIndividualized approach in the management of women with female sexual dysfunction, external genital endometriosis and hyperhomocysteinemia
The problem of treatment of endometriosis in women of reproductive age remains an urgent task for obstetricians and gynecologists, as it has a direct impact on women’s ability to conceive. Overcoming the demographic crisis in Ukraine requires doctors to find new methods and techniques in a personalized approach to the treatment of women with endometriosis. The presence of comorbid pathology in endometriosis, in particular hyperhomocysteinemia (HHC) and female sexual dysfunction (FSD), necessitates individualization of the management of such patients. Objective — to determine the effect of surgical treatment of women with external‑intraoral endometriosis and female sexual dysfunction and hyperhomocysteinemia on the characteristics of their hormonal homeostasis and indicators of FSD. Materials and methods. The study included 19 patients with external‑intrinsic endometriosis and female sexual dysfunction and hyperhomocysteinemia with homozygous form of MTRF gene polymorphism. Surgical intervention in the form of laparoscopic cystectomy was performed in 12 patients (group I). 7 patients refused to undergo surgery (group II). Surgical intervention was performed 6 months after the start of treatment. The hormonal status and parameters of the FSD were studied according to the results of a questionnaire at the time of treatment, 6 months after the start of conservative therapy, and 3 months after surgery. Results. At 3 months after surgery, the values of vitamin D, FSH, LH, estradiol, progesterone, free T, DHEA‑S and 17‑OH were statistically significantly higher in women of group I compared with patients who did not undergo surgery — II (p<0.05), and the levels of homocysteine, TSH, prolactin were lower (p<0.05). In patients of group I, a statistically significant increase in questionnaire scores was noted after surgery compared with patients who did not undergo surgery at a significance level of p<0.001. Against the background of the total duration of treatment (6 months of conservative therapy + 3 months of combined treatment — conservative therapy + surgery) in patients of group I with a homozygous mutation, it was possible to achieve normalization of the FSD in all 12 (100.0%) patients. In patients who did not undergo surgery, no normalization of FSD was observed. Conclusions. The treatment of women with FSD and external genital endometriosis should be individualized, taking into account the entire clinical problem, including the impact of the disease and the impact of its treatment on the quality of life. Pregravidar preparation of women with LBP and BPH and hypoandrogenism in homozygous carriage of MTRF polymorphism genes should include surgical removal of ovarian endometrioma to improve LBP and hormonal background for pregnancy.
- Open Access
- 27 December 2024
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 20 (8) , 607-612
The role of endogenous insulin in patients with acute pancreatitis
Background. Acute pancreatitis is an inflammatory disease of the exocrine part of the pancreas, accompanied by various complications and further development of necrosis of the gland and parapancreatic tissue with possible secondary infection. The study of experimental models shows that the acinar cells surrounding the islets of Langerhans remain relatively intact, indicating that endogenous insulin is a protective factor for the pancreatic parenchyma. The purpose of the study was to determine the dependence of endogenous insulin levels on the extent of pancreatic parenchymal damage. Materials and methods. Prospective analysis of endogenous insulin levels in 51 patients with acute pancreatitis. Results. Comparison of the mean values of endogenous insulin revealed that in patients with necrotizing pancreatitis, the median value was statistically significantly lower than in patients without pancreatic necrosis (p < 0.001). Moreover, in pancreatic necrosis, the determined level of endogenous insulin did not exceed 9 mcIU/ml and in 7 (13.7 %) patients, insulin was below the reference values. ROC analysis showed that low endogenous insulin is a risk factor for pancreatic necrosis. The threshold value of endogenous insulin, at which pancreatic necrosis was most often diagnosed, was determined, cut-off value of 5.3 mcIU/ml, AUC of 0.96 (95% CI 0.92–1.00) (sensitivity 91.89 % (95% CI 78.09–98.3 %), specificity 71.43 % (95% CI 41.9–91.61 %), PPV 89.47 % (95% CI 78.69–95.14 %), NPV 76.92 % (95% CI 51.74–91.2 %)). Conclusions. There was a statistically significant difference between the mean insulin values depending on the volume and location of pancreatic parenchymal damage (p < 0.001). In patients without pancreatic necrosis, endogenous insulin was statistically significantly higher than in those with pancreatic necrosis (p < 0.001). Binomial logistic regression analysis showed that the development of pancreatic necrosis in patients with acute pancreatitis significantly depended on the values of endogenous insulin at hospitalization. The level of endogenous insulin may be an additional indicator of the acute pancreatitis severity and the formation of necrotic changes in the pancreatic tissue, which will allow for correct initiation of treatment.
- 27 December 2024
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 20 (8) , 607-612
Open AccessThe role of endogenous insulin in patients with acute pancreatitis
Background. Acute pancreatitis is an inflammatory disease of the exocrine part of the pancreas, accompanied by various complications and further development of necrosis of the gland and parapancreatic tissue with possible secondary infection. The study of experimental models shows that the acinar cells surrounding the islets of Langerhans remain relatively intact, indicating that endogenous insulin is a protective factor for the pancreatic parenchyma. The purpose of the study was to determine the dependence of endogenous insulin levels on the extent of pancreatic parenchymal damage. Materials and methods. Prospective analysis of endogenous insulin levels in 51 patients with acute pancreatitis. Results. Comparison of the mean values of endogenous insulin revealed that in patients with necrotizing pancreatitis, the median value was statistically significantly lower than in patients without pancreatic necrosis (p < 0.001). Moreover, in pancreatic necrosis, the determined level of endogenous insulin did not exceed 9 mcIU/ml and in 7 (13.7 %) patients, insulin was below the reference values. ROC analysis showed that low endogenous insulin is a risk factor for pancreatic necrosis. The threshold value of endogenous insulin, at which pancreatic necrosis was most often diagnosed, was determined, cut-off value of 5.3 mcIU/ml, AUC of 0.96 (95% CI 0.92–1.00) (sensitivity 91.89 % (95% CI 78.09–98.3 %), specificity 71.43 % (95% CI 41.9–91.61 %), PPV 89.47 % (95% CI 78.69–95.14 %), NPV 76.92 % (95% CI 51.74–91.2 %)). Conclusions. There was a statistically significant difference between the mean insulin values depending on the volume and location of pancreatic parenchymal damage (p < 0.001). In patients without pancreatic necrosis, endogenous insulin was statistically significantly higher than in those with pancreatic necrosis (p < 0.001). Binomial logistic regression analysis showed that the development of pancreatic necrosis in patients with acute pancreatitis significantly depended on the values of endogenous insulin at hospitalization. The level of endogenous insulin may be an additional indicator of the acute pancreatitis severity and the formation of necrotic changes in the pancreatic tissue, which will allow for correct initiation of treatment.
- Open Access
- 30 September 2024
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 3,p. 23-27
Reduction in the level of dehydroepiandrosterone as an indicator of stress-associated reproductive health disorders. Review
The issue of changes in reproductive steroidogenesis in women of childbearing age arises from disruptions in the ovarian‑menstrual cycle and their consequences (e.g., infertility, miscarriage, premature delivery, decreased libido, and signs of sexual dysfunction). The war in Ukraine has exacerbated the existing demographic crisis, highlighting the strategic importance of reproduction for the country. Under the conditions of martial law, the stress level in the human body increases, leading to an increase in cortisol levels. The relationship between stress and increased cortisol levels and women’s reproductive function has been sufficiently studied. However, the problem of the correlation between stress, hypercortisolemia, and changes in the level of dehydroepiandrosterone (DHEA), as a precursor of steroidogenesis, and the reproductive function of women remains under active investigation. DHEA is considered a precursor to the production of sex hormones (testosterone, estrogen, progesterone), but it is also produced in greater amounts as a moderator of the stress response. Researchers studying the effects of DHEA on the human body note that the ratio of DHEA to cortisol has been associated with increased stress resistance: with DHEA levels higher than cortisol levels, stress resistance increases, and women experience fewer negative consequences from the same stressors compared to individuals with a lower DHEA/cortisol ratio. Researchers of menstrual function in teenagers have reached similar conclusions. When reviewing recent papers on the value of DHEA levels for ovarian reserve, we found numerous studies reporting improvements in IVF outcomes in women with low follicular reserves. It is to the works of reproductive scientists that we owe information about the positive role of pro‑androgenic steroids in improving fertility, especially in the context of using androgens in ovulation stimulation protocols. Taking into account all of the above, we consider the use of DHEA in the pre‑gravid stage to be promising for women with hypoandrogenism, stress‑related menstrual disorders, and functionally increased cortisol levels.
- 30 September 2024
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 3,p. 23-27
Open AccessReduction in the level of dehydroepiandrosterone as an indicator of stress-associated reproductive health disorders. Review
The issue of changes in reproductive steroidogenesis in women of childbearing age arises from disruptions in the ovarian‑menstrual cycle and their consequences (e.g., infertility, miscarriage, premature delivery, decreased libido, and signs of sexual dysfunction). The war in Ukraine has exacerbated the existing demographic crisis, highlighting the strategic importance of reproduction for the country. Under the conditions of martial law, the stress level in the human body increases, leading to an increase in cortisol levels. The relationship between stress and increased cortisol levels and women’s reproductive function has been sufficiently studied. However, the problem of the correlation between stress, hypercortisolemia, and changes in the level of dehydroepiandrosterone (DHEA), as a precursor of steroidogenesis, and the reproductive function of women remains under active investigation. DHEA is considered a precursor to the production of sex hormones (testosterone, estrogen, progesterone), but it is also produced in greater amounts as a moderator of the stress response. Researchers studying the effects of DHEA on the human body note that the ratio of DHEA to cortisol has been associated with increased stress resistance: with DHEA levels higher than cortisol levels, stress resistance increases, and women experience fewer negative consequences from the same stressors compared to individuals with a lower DHEA/cortisol ratio. Researchers of menstrual function in teenagers have reached similar conclusions. When reviewing recent papers on the value of DHEA levels for ovarian reserve, we found numerous studies reporting improvements in IVF outcomes in women with low follicular reserves. It is to the works of reproductive scientists that we owe information about the positive role of pro‑androgenic steroids in improving fertility, especially in the context of using androgens in ovulation stimulation protocols. Taking into account all of the above, we consider the use of DHEA in the pre‑gravid stage to be promising for women with hypoandrogenism, stress‑related menstrual disorders, and functionally increased cortisol levels.